1 August 2022 false Taxfiler 2024.1 10001886business:PrivateLimitedCompanyLtd2022-08-012023-07-31 100018862022-07-31 100018862022-08-012023-07-31 10001886business:AuditExempt-NoAccountantsReport2022-08-012023-07-31 10001886business:FilletedAccounts2022-08-012023-07-31 100018862023-07-31 10001886business:Director12022-08-012023-07-31 10001886business:Director22022-08-012023-07-31 10001886business:Director32022-08-012023-07-31 10001886business:Director42022-08-012023-07-31 10001886business:Director52022-08-012023-07-31 10001886business:RegisteredOffice2022-08-012023-07-31 100018862022-07-31 10001886core:WithinOneYear2023-07-31 10001886core:WithinOneYear2022-07-31 10001886countries:EnglandWales2022-08-012023-07-31 100018862021-08-012022-07-31 10001886business:Micro-entities2022-08-012023-07-31 iso4217:GBP xbrli:pure
Company Registration No. 10001886 (England and Wales)
Ceryx Medical Limited Unaudited accounts for the year ended 31 July 2023
Ceryx Medical Limited Annual report and unaudited accounts for the year ended 31 July 2023
CONTENTS
PAGE
- 2 -
Ceryx Medical Limited Company Information for the year ended 31 July 2023
Directors
J Caddell J F R Paton S Plant C R Taylor Parkwalk Advisors Ltd
Company Number
10001886 (England and Wales)
Registered Office
4th Floor 14 Museum Place Cardiff CF10 3BH
Accountants
Mutu Accountancy Ltd 7 Chelsea Road Bath BA1 3DU
- 3 -
Ceryx Medical Limited Statement of Financial Position as at 31 July 2023
2023 
2022 
£ 
£ 
Fixed assets
2,141,926 
926,026 
Current assets
2,199,765 
3,868,820 
Prepayments and accrued income
50,034 
32,567 
Creditors: amounts falling due within one year
(55,441)
(47,363)
Net current assets
2,194,358 
3,854,024 
Total assets less current liabilities
4,336,284 
4,780,050 
Accruals and deferred income
(3,047)
(13,937)
Net assets
4,333,237 
4,766,113 
Capital and reserves
4,333,237 
4,766,113 
NOTES TO THE ACCOUNTS
1 Statutory information
Ceryx Medical Limited is a private company, limited by shares, registered in England and Wales, registration number 10001886. The registered office is 4th Floor, 14 Museum Place, Cardiff, CF10 3BH.
2 Guarantees and other financial commitments
The company has issued options over its unissued shares to certain employees. The cost of equity-settled transactions is measured by reference to the fair value of the equity instruments granted. at the date at which they are granted and is recognised as an expense over the vesting period, which ends on the date on which the option holder becomes. fully entitled to the award. Fair value. is. determined using the Black Scholes pricing model. At each balance sheet date before vesting, the cumulative expense is calculated, representing the extent to which the vesting period has expired and management's best estimate of the achievement or otherwise of non-market conditions and of the number of equity instruments that will ultimately vest. The movement in cumulative.expense since the previous balance sheet date is recognised in the profit and loss account, with a corresponding entry in equity. No expense has been recognised in the year under -review, on the grounds that the expense· is immaterial.
3 Average number of employees
During the year the average number of employees was 5 (2022: 4).
- 4 -
Ceryx Medical Limited Statement of Financial Position as at 31 July 2023 (continued)
For the year ending 31 July 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and FRS 105, The Financial Reporting Standard applicable to the Micro-entities Regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
Approved by the board on 31 October 2023
S Plant Director Company Registration No. 10001886
- 5 -